Annual Operating Expenses
$862.40 M
-$451.92 M-34.38%
31 December 2023
Summary:
Royalty Pharma annual total operating expenses is currently $862.40 million, with the most recent change of -$451.92 million (-34.38%) on 31 December 2023. During the last 3 years, it has risen by +$400.50 million (+86.71%). RPRX annual operating expenses is now -34.38% below its all-time high of $1.31 billion, reached on 31 December 2022.RPRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
-$170.38 M
-$438.02 M-163.66%
30 September 2024
Summary:
Royalty Pharma quarterly total operating expenses is currently -$170.38 million, with the most recent change of -$438.02 million (-163.66%) on 30 September 2024. Over the past year, it has dropped by -$555.25 million (-144.27%). RPRX quarterly operating expenses is now -126.55% below its all-time high of $641.75 million, reached on 31 March 2024.RPRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.4% | -144.3% |
| 3 y3 years | +86.7% | -160.3% |
| 5 y5 years | +100.3% | -149.8% |
RPRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -34.4% | +86.7% | -126.5% | at low |
| 5 y | 5 years | -34.4% | +206.6% | -126.5% | +80.5% |
| alltime | all time | -34.4% | +206.6% | -126.5% | +80.5% |
Royalty Pharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$170.38 M(-163.7%) |
| June 2024 | - | $267.64 M(-58.3%) |
| Mar 2024 | - | $641.75 M(-3913.6%) |
| Dec 2023 | $862.40 M(-34.4%) | -$16.83 M(-104.4%) |
| Sept 2023 | - | $384.87 M(+33.0%) |
| June 2023 | - | $289.36 M(+41.2%) |
| Mar 2023 | - | $205.00 M(-52.6%) |
| Dec 2022 | $1.31 B(+53.1%) | $432.58 M(+13.5%) |
| Sept 2022 | - | $381.25 M(+141.1%) |
| June 2022 | - | $158.16 M(-53.8%) |
| Mar 2022 | - | $342.33 M(-18.9%) |
| Dec 2021 | $858.75 M | $422.28 M(+49.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $282.72 M(-248.8%) |
| June 2021 | - | -$189.99 M(-155.3%) |
| Mar 2021 | - | $343.73 M(+78.1%) |
| Dec 2020 | $461.90 M(-157.1%) | $193.03 M(+593.6%) |
| Sept 2020 | - | $27.83 M(-72.6%) |
| June 2020 | - | $101.59 M(-27.2%) |
| Mar 2020 | - | $139.45 M(-115.9%) |
| Dec 2019 | -$808.92 M(-287.9%) | -$874.43 M(+1181.8%) |
| Sept 2019 | - | -$68.22 M(-152.6%) |
| June 2019 | - | $129.75 M(+3157.6%) |
| Mar 2019 | - | $3.98 M |
| Dec 2018 | $430.45 M(-34.6%) | - |
| Dec 2017 | $658.24 M | - |
FAQ
- What is Royalty Pharma annual total operating expenses?
- What is the all time high annual operating expenses for Royalty Pharma?
- What is Royalty Pharma annual operating expenses year-on-year change?
- What is Royalty Pharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Royalty Pharma?
- What is Royalty Pharma quarterly operating expenses year-on-year change?
What is Royalty Pharma annual total operating expenses?
The current annual operating expenses of RPRX is $862.40 M
What is the all time high annual operating expenses for Royalty Pharma?
Royalty Pharma all-time high annual total operating expenses is $1.31 B
What is Royalty Pharma annual operating expenses year-on-year change?
Over the past year, RPRX annual total operating expenses has changed by -$451.92 M (-34.38%)
What is Royalty Pharma quarterly total operating expenses?
The current quarterly operating expenses of RPRX is -$170.38 M
What is the all time high quarterly operating expenses for Royalty Pharma?
Royalty Pharma all-time high quarterly total operating expenses is $641.75 M
What is Royalty Pharma quarterly operating expenses year-on-year change?
Over the past year, RPRX quarterly total operating expenses has changed by -$555.25 M (-144.27%)